BMRN — BIOMARIN PHARMACEUTICAL INC catalysts
Next verified catalyst
2027-03-01 — A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or Af · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-03 (month) in 4mo
ESTIMATED |
READOUT
A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth Du
Phase 2 · Noonan Syndrome |
BMRN BIOMARIN PHARMACEUTICAL INC | Vosoritide Injection |
ClinicalTrials.gov ↗
✓ Source-checked 2026-10-31
Sponsor-projected date — can change
|